Syros Pharmaceuticals Inc (SYRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,146 | -86,558 | -62,745 | -36,718 | -14,228 |
| Depreciation Amortization | 866 | 3,724 | 2,766 | 1,821 | 898 |
| Accounts receivable | -203 | 7 | 7 | 7 | 7 |
| Accounts payable and accrued liabilities | -969 | 48 | 334 | -6 | 63 |
| Other Working Capital | -6,294 | -10,602 | -10,076 | -6,669 | -3,920 |
| Other Operating Activity | 1,729 | -6,159 | -6,857 | -6,879 | -4,810 |
| Operating Cash Flow | $-30,017 | $-99,540 | $-76,571 | $-48,444 | $-21,990 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,511 | -51,408 | -51,408 | -34,417 | N/A |
| PPE Investments | -128 | -1,245 | -1,000 | -690 | -262 |
| Investing Cash Flow | $7,383 | $-52,653 | $-52,408 | $-35,107 | $-262 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -70 | -265 | -196 | -129 | -64 |
| Common Stock Issued | 1 | 70,817 | 70,647 | 70,647 | 70,510 |
| Other Financing Activity | -24 | -41 | -36 | -36 | -36 |
| Financing Cash Flow | $-93 | $70,511 | $70,415 | $70,482 | $70,410 |
| Beginning Cash Position | 95,388 | 177,070 | 177,070 | 177,070 | 177,070 |
| End Cash Position | 72,661 | 95,388 | 118,506 | 164,001 | 225,228 |
| Net Cash Flow | $-22,727 | $-81,682 | $-58,564 | $-13,069 | $48,158 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,017 | -99,540 | -76,571 | -48,444 | -21,990 |
| Capital Expenditure | -128 | -1,245 | -1,000 | -690 | -262 |
| Free Cash Flow | -30,145 | -100,785 | -77,571 | -49,134 | -22,252 |